Yüklüyor......
Aspirin for everyone older than 50?: FOR
Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet s...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group Ltd.
2005
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC558385/ https://ncbi.nlm.nih.gov/pubmed/15961818 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|